Junfang Yang

1.4k total citations
69 papers, 826 citations indexed

About

Junfang Yang is a scholar working on Oncology, Molecular Biology and Rheumatology. According to data from OpenAlex, Junfang Yang has authored 69 papers receiving a total of 826 indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Oncology, 16 papers in Molecular Biology and 10 papers in Rheumatology. Recurrent topics in Junfang Yang's work include CAR-T cell therapy research (44 papers), Pelvic floor disorders treatments (10 papers) and Acute Lymphoblastic Leukemia research (10 papers). Junfang Yang is often cited by papers focused on CAR-T cell therapy research (44 papers), Pelvic floor disorders treatments (10 papers) and Acute Lymphoblastic Leukemia research (10 papers). Junfang Yang collaborates with scholars based in China, United States and Belgium. Junfang Yang's co-authors include Peihua Lu, Xian Zhang, Jingjing Li, Jianping Zhang, Xin‐an Lu, Xiaosu Zhou, Min Xiong, Hongxing Liu, Jianqiang Li and Dan Song and has published in prestigious journals such as Nature Materials, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Junfang Yang

66 papers receiving 804 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junfang Yang China 15 636 226 225 158 132 69 826
Xia Mao China 16 512 0.8× 235 1.0× 123 0.5× 104 0.7× 79 0.6× 66 741
Farzana Nazimuddin United States 9 865 1.4× 213 0.9× 262 1.2× 234 1.5× 108 0.8× 11 958
Sarah Wright United Kingdom 10 274 0.4× 171 0.8× 126 0.6× 121 0.8× 48 0.4× 30 627
Eric Chen United States 7 556 0.9× 176 0.8× 216 1.0× 158 1.0× 89 0.7× 12 826
Carrie Yuen United States 7 284 0.4× 163 0.7× 102 0.5× 70 0.4× 32 0.2× 19 470
Tatsunori Goto Japan 14 435 0.7× 216 1.0× 146 0.6× 163 1.0× 62 0.5× 48 723
Margherita Norelli Italy 6 1.2k 1.9× 388 1.7× 352 1.6× 395 2.5× 208 1.6× 9 1.5k
Guanghua Chen China 10 508 0.8× 152 0.7× 102 0.5× 81 0.5× 38 0.3× 23 630
Margot J. Pont United States 13 600 0.9× 326 1.4× 118 0.5× 167 1.1× 66 0.5× 27 798

Countries citing papers authored by Junfang Yang

Since Specialization
Citations

This map shows the geographic impact of Junfang Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junfang Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junfang Yang more than expected).

Fields of papers citing papers by Junfang Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junfang Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junfang Yang. The network helps show where Junfang Yang may publish in the future.

Co-authorship network of co-authors of Junfang Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Junfang Yang. A scholar is included among the top collaborators of Junfang Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junfang Yang. Junfang Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Ye, Dekai, Lanyi Xiang, Zihan He, et al.. (2024). A drug-mediated organic electrochemical transistor for robustly reusable biosensors. Nature Materials. 23(11). 1547–1555. 22 indexed citations
5.
Lu, Peihua, Junfang Yang, Jingjing Li, et al.. (2024). Nanobody-based naturally selected CD7-targeted CAR-T therapy for acute myeloid leukemia. Blood. 145(10). 1022–1033. 12 indexed citations
7.
Zhang, Kun, et al.. (2023). Midterm comparison of laparoscopic high uterosacral ligament suspension and sacrocolpopexy in the treatment of moderate to severe apical prolapse. International Urogynecology Journal. 34(10). 2501–2506. 2 indexed citations
8.
Yang, Junfang, Jiaping He, Xian Zhang, et al.. (2022). Next-day manufacture of a novel anti-CD19 CAR-T therapy for B-cell acute lymphoblastic leukemia: first-in-human clinical study. Blood Cancer Journal. 12(7). 104–104. 69 indexed citations
9.
Yang, Junfang, Xiao Yan Yang, Ying Liu, et al.. (2021). A Novel and Successful Patient or Donor-Derived CD7-Targeted CAR T-Cell Therapy for Relapsed or Refractory T-Cell Lymphoblastic Lymphoma (R/R T-LBL). Blood. 138(Supplement 1). 652–652. 9 indexed citations
10.
Yang, Junfang, Xian Zhang, Ying Liu, et al.. (2021). High Effectiveness and Safety of Anti-CD7 CAR T-Cell Therapy in Treating Relapsed or Refractory (R/R) T-Cell Acute Lymphoblastic Leukemia (T-ALL). Blood. 138(Supplement 1). 473–473. 9 indexed citations
12.
Yang, Junfang, et al.. (2021). Long-Term Observation on Postoperative Recurrence and Complications of Transvaginal Mesh Surgery for Pelvic Organ Prolapse. Gynecologic and Obstetric Investigation. 87(1). 30–37. 5 indexed citations
13.
Zhang, Kun, et al.. (2020). Long-term efficacy and patient satisfaction of Le Fort colpocleisis for the treatment of severe pelvic organ prolapse. International Urogynecology Journal. 32(4). 879–884. 6 indexed citations
14.
Zhao, Yu, Zhongfeng Liu, Xuan Wang, et al.. (2019). Treatment with Humanized Selective CD19CAR-T Cells Shows Efficacy in Highly Treated B-ALL Patients Who Have Relapsed after Receiving Murine-Based CD19CAR-T Therapies. Clinical Cancer Research. 25(18). 5595–5607. 34 indexed citations
15.
Yang, Junfang, Pengfei Jiang, Xian Zhang, et al.. (2019). Anti-CD19/CD22 Dual CAR-T Therapy for Refractory and Relapsed B-Cell Acute Lymphoblastic Leukemia. Blood. 134(Supplement_1). 284–284. 21 indexed citations
16.
Yang, Junfang, Jianqiang Li, Xian Zhang, et al.. (2018). A Feasibility and Safety Study of CD19 and CD22 Chimeric Antigen Receptors-Modified T Cell Cocktail for Therapy of B Cell Acute Lymphoblastic Leukemia. Blood. 132(Supplement 1). 277–277. 19 indexed citations
17.
Zhang, Xian, et al.. (2017). A 11-Year Clinical Summary of DC - CIK / NK Cell Immunotherapy for 152 Patients with Acute Myeloid Leukemia. Blood. 130. 1369–1369. 1 indexed citations
18.
Yang, Junfang, et al.. (2016). Tissue Reactions to Heterogenic and Allogeneic Acellular Dermal Matrix Mesh Placed in the Vesicovaginal Space in a Rabbit Model. Gynecologic and Obstetric Investigation. 82(5). 437–445. 4 indexed citations
19.
Wang, Yu, et al.. (2015). [Relevance between expectations before treatment, new symptoms and satisfaction after treatment in patients with pelvic organ prolapse].. PubMed. 50(9). 664–7. 1 indexed citations
20.
Yang, Junfang, et al.. (2012). Local reaction to the different meshes at the vesicovaginal space in rabbit model. International Urogynecology Journal. 23(5). 605–611. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026